InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Karl Hård af Segerstad. Director active across 1 company, notably Egetis Therapeutics AB (publ). In total, 2 filings have been published. History available since 11 May 2026. The latest transaction was filed on 13 May 2026 (Sale). Regulator: FIN-FSA. The full history is accessible without signup.
2 of 2 declarations